What Happens to Claim Scope When “Comprise” and “Consists Of” Are Used Together in the Same Claim?
On January 7, 2020, in Amgen Inc. v. Amneal Pharmaceuticals, the CAFC decided that the open ended term “comprising” controlled,…
On January 7, 2020, in Amgen Inc. v. Amneal Pharmaceuticals, the CAFC decided that the open ended term “comprising” controlled,…
The USPTO examiners use the broadest reasonable interpretation (BRI) when construing claims during examination of patent applications. The BRI standard…